X4 Pharmaceuticals, Inc.

8-K Director or officer change; Regulation FD disclosure Jul 1, 2026 8-K/A Director or officer change; Shareholder vote results May 13, 2026 8-K Director or officer change; Shareholder vote results May 12, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement Oct 27, 2025 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Sep 17, 2025 8-K Director or officer change Aug 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Entered a material agreement Jun 23, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2025 8-K Amended charter or bylaws; Other events Apr 24, 2025 8-K Shareholder vote results Apr 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Other events Mar 3, 2025 8-K Exit or disposal costs; Regulation FD disclosure Feb 6, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Regulation FD disclosure; Other events Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Delisting notice or listing-rule failure Aug 16, 2024 8-K Regulation FD disclosure Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure Jul 19, 2024 8-K Regulation FD disclosure; Other events Jun 27, 2024 8-K Shareholder vote results Jun 11, 2024 8-K Regulation FD disclosure May 22, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Director or officer change; Regulation FD disclosure; Other events May 9, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Regulation FD disclosure; Other events Apr 29, 2024 8-K Regulation FD disclosure; Other events Apr 29, 2024